|
Sunday, 08/01/2010
|
Application of Partial Order to Stream Channel Assessment and Bridge Infrastructure Management
Jessica T. Newlin, Bucknell University; Ganapati P. Patil, Penn State
2:35 PM
|
A Foundation for Dynamic Graphical Data Analysis
Edward C. Chao, Data Numerica Institute, Inc.; Jianliang Jin, Annpro Analytic Technologies, Inc.
4:05 PM
|
Exploring Center Effects in Randomized Studies with Censored Endpoints
Richard McNally, Celgene Corporation; Sarah H. Kogut, Celgene Corporation
4:35 PM
|
Visualizing Model Uncertainty with Many Parameters
David W. Scott, Rice University
4:50 PM
|
A Projection of True-early-detection, No-early-detection, Overdiagnosis and Not-so-necessary Probabilities in Tumor Screening
Dongfeng Wu, University of Louisville; Gary L. Rosner, MD Anderson Cancer Center
5:25 PM
|
|
Monday, 08/02/2010
|
Verbal Paradata and Survey Question Content: How Question Sensitivity and Cognitive Complexity Influence the Way Answers (and Nonanswers) to Survey Questions Are Delivered
Matt Jans, U.S. Census Bureau
9:35 AM
|
Unmeasured Covariates in Repeated Observational Studies
Bo Lu, The Ohio State University; Chih-Lin Li, The Ohio State University
11:15 AM
|
Confidence Interval Based on Central Limit Theorem for Correlated Binary Observations
Jongphil Kim, Moffitt Cancer Center & Research Institute; Ji-Hyun Lee, Moffitt Cancer Center & Research Institute
11:50 AM
|
Optimal Weight in Estimating the Receiver Operating Characteristic Curve Area Using Longitudinal Data
Yougui Wu, University of South Florida
2:05 PM
|
Evaluating Screening Tests for Chlamydia trachomatis in the Absence of a Gold Standard Test
Alula Hadgu, CDC; Liangliang Wang, The University of British Columbia; Nandini Dendukuri, McGill University
2:20 PM
|
|
Tuesday, 08/03/2010
|
An Informatics Center for Online Longitudinal Data Analysis
Edward C. Chao, Data Numerica Institute, Inc.; Tao Qi, Annpro Analytic Technologies, Inc.
|
Developing Targeted Protein Measurement for Label-Free Multiple Reaction Monitoring
Dean Billheimer, The University of Arizona
8:55 AM
|
Handling Missing Data in Rheumatoid Arthritis Trials
Guoguang Ma, Amgen Inc.; Liyun Ni, Amgen Inc.; Ling Chen, Washington University School of Medicine
11:05 AM
|
Use Multiple Imputation to Handle Missing Data in Longitudinal Clinical Trials with Multiple Correlated Endpoints
Yahong Peng, Pfizer Inc.; Lian Liu, Roche Product Development in Asia Pacific; Ruifeng Xu, Merck Research Laboratories
11:20 AM
|
Simultaneous Sensitivity Analysis for Observational Studies Using Full Matching with Multiple Controls
Dylan Small, University of Pennsylvania; Joseph L. Gastwirth, Washington University; Abba Krieger, University of Pennsylvania; Paul Rosenbaum, University of Pennsylvania
11:35 AM
|
Using IV with Subjective Assumptions to Construct Treatment Effect Bounds on Continuous Outcomes in Observational Studies
Joseph W. Hogan, Brown University; Tao Liu, Brown University
2:05 PM
|
Compare Sensitivity of Multiple Measures in Discerning a Treatment Effect
Hongwei Wang, Merck & Co., Inc.; Arvind K. Shah, Merck Research Laboratories
2:35 PM
|
Missing Data Methodology: Past, Present, and Future Trends
Cristina Labrador Sotto, I-Biostat
2:45 PM
|
Robust ROC Analysis Using Auxiliary Variables in the Presence of Missing Biomarker Values
Xiaoxi Zhang, Pfizer Inc.; Qi Long, Emory University
3:05 PM
|
Addressing the Missing Data Problem in Clinical Trials
Linda Yau, Genentech
3:25 PM
|
|
Wednesday, 08/04/2010
|
Estimating accuracy of a diagnostic test with verification bias when the number of observed false negatives is small: a Monte Carlo approach
Li Deng, New England College of Optometry
|
Utility of Positive Controls in Assessing QT Interval Sensitivity
Alan Y. Chiang, Eli Lilly and Company
9:05 AM
|
Analysis and Sensitivity Analysis for Incomplete Data
Geert Molenberghs, I-BioStat
10:35 AM
|
Sensitivity Analyses Adjusting for Early Discontinuation of Study Medication in the RE-LY Trial: An Open-Label, Randomized, Active-Controlled, Time-to-Event Noninferiority Trial
Xiuyu Cong, Boehringer Ingelheim Pharmaceuticals, Inc.; Qiqi Deng, Boehringer Ingelheim Pharmaceuticals, Inc.; Susan Q. Wang, Boehringer Ingelheim Pharmaceuticals, Inc.
11:15 AM
|
Using Gaussian Stochastic Processes to Improve Fourier Amplitude Sensitivity Test
Amy Hoeksema, Iowa State University; Max Morris, Iowa State University
11:35 AM
|
Evaluating Statistical Hypotheses Using Nonidentifiable Estimating Functions
Guanqun Cao, Michigan State University; David Todem, Michigan State University; Lijian Yang, Michigan State University; Jason Peter Fine, The University of North Carolina at Chapel Hill
11:35 AM
|
The Role of Bayesian Statistics in Confirmatory Drug Development Trials
David Ohlssen, Novartis Pharmaceuticals Corporation
2:30 PM
|
Evaluation and Interpretation of Diagnostic Tests
Bipasa Biswas, FDA/CDRH
2:45 PM
|
Sensitivity Analysis for PFS
Alicia Zhang, Amgen Inc.; Alan Rong, Amgen Inc.; Ying Tian, Amgen Inc.; Michael Wolf, Amgen Inc.
3:35 PM
|
|